144 related articles for article (PubMed ID: 9664954)
1. Conversion of renal transplant recipients from cyclosporin (neoral) to tacrolimus (prograf) for haemolytic uraemic syndrome.
Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA
Transpl Int; 1998; 11 Suppl 1():S98-9. PubMed ID: 9664954
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
Abraham KA; Little MA; Dorman AM; Walshe JJ
Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
[TBL] [Abstract][Full Text] [Related]
3. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.
Myers JN; Shabshab SF; Burton NA; Nathan SD
J Heart Lung Transplant; 1999 Oct; 18(10):1024-6. PubMed ID: 10561115
[TBL] [Abstract][Full Text] [Related]
4. Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer?
Grupp C; Schmidt F; Braun F; Lorf T; Ringe B; Müller GA
Nephrol Dial Transplant; 1998 Jul; 13(7):1629-31. PubMed ID: 9681701
[No Abstract] [Full Text] [Related]
5. The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic-uraemic syndrome.
Richardson D; Jones CH; Newstead CG; Will EJ; Lodge JP
Nephrol Dial Transplant; 1996 Dec; 11(12):2498-500. PubMed ID: 9017633
[No Abstract] [Full Text] [Related]
6. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient.
Kiykim AA; Ozer C; Yildiz A; Tiftik N; Senli M; Kelebek E; Doruk E; Akbay E
Nephrol Dial Transplant; 2004 Oct; 19(10):2653-6. PubMed ID: 15388824
[No Abstract] [Full Text] [Related]
7. Uneventful re-treatment with cyclosporin in two cases of cyclosporin-induced haemolytic uraemic syndrome.
Guella A; Daoud M; Al Dayel A
Nephrol Dial Transplant; 1998 Jul; 13(7):1864-5. PubMed ID: 9681750
[No Abstract] [Full Text] [Related]
8. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
Wen YK; Chen ML
Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin-induced haemolytic-uraemic syndrome presenting as primary graft dysfunction.
Kohli HS; Sud K; Jha V; Gupta KL; Minz M; Joshi K; Sakhuja V
Nephrol Dial Transplant; 1998 Nov; 13(11):2940-2. PubMed ID: 9829509
[No Abstract] [Full Text] [Related]
10. Cyclosporin conversion to CellCept in a cadaveric renal allograft recipient with hemolytic uremic syndrome.
Said T; al-Mousawi M; Samhan M; Lao M
Transplant Proc; 1999 Dec; 31(8):3295-7. PubMed ID: 10616482
[No Abstract] [Full Text] [Related]
11. Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation.
Furmańczyk A; Komuda-Leszek E; Durlik M
Ann Transplant; 2009; 14(4):47-51. PubMed ID: 20009155
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
[TBL] [Abstract][Full Text] [Related]
14. Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series.
Lovric S; Kielstein JT; Kayser D; Bröcker V; Becker JU; Hiss M; Schiffer M; Sommerwerck U; Haller H; Strüber M; Welte T; Gottlieb J
Nephrol Dial Transplant; 2011 Sep; 26(9):3032-8. PubMed ID: 21310739
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation.
Lapointe M; Baillie GM; Bhaskar SS; Richardson MS; Self SE; Baliga PK; Rajagopalan PR
Clin Transplant; 1999 Dec; 13(6):526-30. PubMed ID: 10617244
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient.
Gray JM; Ameduri RK
Pediatr Transplant; 2016 Sep; 20(6):866-7. PubMed ID: 27371345
[TBL] [Abstract][Full Text] [Related]
17. Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection.
Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA
Transpl Int; 1998; 11 Suppl 1():S78-81. PubMed ID: 9664949
[TBL] [Abstract][Full Text] [Related]
18. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
[No Abstract] [Full Text] [Related]
19. FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipient.
Abdalla AH; al-Sulaiman MH; al-Khader AA
Transpl Int; 1994 Aug; 7(5):382-4. PubMed ID: 7527640
[TBL] [Abstract][Full Text] [Related]
20. Conversion from tacrolimus to cyclosporin in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison.
Higgins RM; Hart P; Lam FT; Kashi H
Transplantation; 2000 Jul; 70(1):199-202. PubMed ID: 10919600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
